Daily Stock Analysis, OFIX, Orthofix International NV, priceseries

Orthofix International NV. Daily Stock Analysis
Stock Information
Open
35.96
Close
34.86
High
36.08
Low
34.83
Previous Close
35.83
Daily Price Gain
-0.97
YTD High
36.13
YTD High Date
Mar 4, 2022
YTD Low
28.66
YTD Low Date
Jan 28, 2022
YTD Price Change
2.49
YTD Gain
7.69%
52 Week High
47.89
52 Week High Date
Mar 9, 2021
52 Week Low
28.65
52 Week Low Date
Dec 15, 2021
52 Week Price Change
-10.82
52 Week Gain
-23.69%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 26. 2018
54.81
Mar 22. 2018
59.03
18 Trading Days
7.71%
Link
LONG
Jan 30. 2019
52.91
Feb 26. 2019
62.57
18 Trading Days
18.26%
Link
LONG
Apr 6. 2020
27.37
May 4. 2020
33.62
19 Trading Days
22.82%
Link
LONG
Oct 2. 2020
31.35
Oct 20. 2020
33.87
12 Trading Days
8.04%
Link
LONG
Nov 3. 2020
32.65
Nov 19. 2020
35.55
12 Trading Days
8.87%
Link
LONG
Dec 14. 2020
38.64
Jan 4. 2021
41.49
13 Trading Days
7.38%
Link
Company Information
Stock Symbol
OFIX
Exchange
NasdaqGS
Company URL
http://www.orthofix.com
Company Phone
214-937-2000
CEO
Bradley R. Mason
Headquarters
-
Business Address
7 ABRAHAM DE VEERSTRAAT, CURACAO, NETHERLANDS ANTILLES, NETHERLANDS ANTILLES 00000
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000884624
About

Orthofix International NV is engaged in the research, development, and market of orthopedic solutions. It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology. The Biologics segment includes regenerative products. The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment develops and sells implant products for spine surgeries. The company was founded on October 19, 1987 and is headquartered in Willemstad, Netherlands.

Description

Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The company markets and distributes its products directly, as well as through independent distributors and independent sales representatives to hospitals, doctors, and other healthcare providers. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.